SEC Form 4 · accession 0001209191-19-005728
Genprex, Inc. · GNPX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John Rodney Varner
Officer — Chief Executive Officer · Director · 10% Owner
Period of report
Jan 25, 2019
Accepted (ET)
Jan 29, 2019 · 2:45 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001595248
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $1.62 | Jan 25, 2019 | A | 615,384 | A | Jan 25, 2022 | Jan 25, 2029 | Common Stock | 615,384 | 615,384 | D |
Explanation of responses
- F1One thirty-sixth (1/36) of the Shares subject to the Option shall vest on each monthly anniversary of January 25, 2019 so that one hundred percent (100%) of the shares subject to the Option are vested on the third anniversary of January 25, 2019.